Cold Plasma Global Market Report 2022

Major players in the cold plasma market are Ethicon Inc., Baxter International Inc., 3M Company, Smith & Nephew plc., Nordson Corporation, Plasma Etch Inc., Adtech Plasma Technology Co., P2i Ltd., Relyon Plasma GmbH, Henniker Plasma, Enercon Industries, AcXys Plasma Technologies, Plasmatreat, Europlasma, SOFTAL, and UNIQAIR Technologies.

The global cold plasma market is expected to grow from $2.03 billion in 2021 to $2.32 billion in 2022 at a compound annual growth rate (CAGR) of 14.07%. The growth is mainly due to the companies' resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $4.04 billion in 2026 at a CAGR of 14.86%.

The cold plasma market consists of sales of cold plasma by entities (organizations, sole traders, and partnerships) that is also referred to as non-thermal atmospheric pressure plasma and is used in industries such as plastics and polymers, textiles, electronics, food and agriculture, and medicine. Cold plasma is a reactive gas containing different amounts of ions, electrons, and neutral particles in the air that allows us to generate ozone from oxygen molecules by means of electrical discharges via atmospheric gases.

The main types of cold plasma by regime are atmospheric cold plasma and low-pressure cold plasma. Atmospheric cold plasma is an ionised gas with a near room temperature. It is a source of reactive species, neutral particles, electromagnetic fields, and UV radiation that may be controlled. Cold plasma is used on the basis of technology, which includes remote treatment, direct treatment, and electrode contact. These are used for wood healing, blood coagulation, dentistry, cancer treatment, and other medical applications. Cold plasma is also used by end users such as automotives, electronics & semiconductors, food processing & packaging, medical, aerospace, and polymers & plastics.

Asia-Pacific was the largest region in the cold plasma market in 2021. North America is expected to be the fastest-growing region in the forecast period. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The increased use of cold plasma technology across various industries is expected to propel the growth of the cold plasma market. Cold plasma technology is becoming more popular in medical and industrial applications such as healthcare devices and diagnostics. Cold plasma therapy is also being promoted as a viable treatment for the continuing COVID-19 outbreak. Cold plasma has the potential to kill bacteria, especially drug-resistant bacteria, preventing further infection and aiding in the treatment of chronic wounds. Cold plasma can help in the hydrophilization process in the textile industry in the treatment of protective clothing and sterile materials to reduce microorganisms. As per the German Federal Statistical Office 2020 report, there are about 83 million people in Germany, of which 16.2 million people are over 67 years of age, and it is projected to reach 21.4 million by 2040. With the increase in the geriatric population, there is also an increase in the diabetic population, which results in chronic wounds such as foot ulcers and thus boosts the overall market. Therefore, the increased use of cold plasma across various industries is driving the growth of the cold plasma market.

Technological advancements are a key trend gaining popularity in the cold plasma market. Technological advancement is the advancement in technology. For instance, in the field of wastewater treatment, cold plasma technology is used to handle problems with the degradation of a variety of aqueous contaminants and water-borne pathogenic microorganisms, including viruses, to a large degree. The World Health Organization estimates that 785 million people have insufficient drinking water supplies, which includes approximately 44 million people who rely on surface water. Furthermore, around two billion people use a drinking water source contaminated by faecal matter, which might result in around 485 000 deaths every year due to diarrhoea (WHO 2019).

In July 2020, Grifols, a prominent developer of plasma-derived pharmaceuticals, acquired GC Pharma Group's plasma fractionation unit and two purification units in Montreal, as well as 11 plasma collection centres in the United States for USD 460 million. This acquisition is aimed at expanding Grifols' plasma collection and fractionation capacity to enable access to plasma-derived medicines worldwide. GC Pharma (GC Pharma), a subsidiary of Green Cross Holdings Corp., provides plasma protein therapeutics and vaccines.

The countries covered in the Cold Plasma Market market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

This product will be delivered within 3-5 business days.